Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. announced its intention to launch a take-over bid for Aurora Cannabis, offering US$4.00 per share, comprising 0.3463 Curaleaf Shares and US$0.75 cash. This represents a 45% premium over Aurora's 30-day VWAP and 110% excluding cash. Curaleaf aims to create the leading global cannabis platform with over US$1.5 billion in LTM revenue and expects US$40 million in annual cost synergies, despite Aurora's refusal to engage in prior discussions.

Curaleaf Holdings, Inc. reported a significant financial turnaround for the second quarter ended June 30, 2026, achieving a net income of $12.5 million, a substantial improvement from a net loss of $53.2 million in the same period last year. The company's total revenues increased by 9.5% to $340.1 million. Additionally, Curaleaf completed a 1-for-3 reverse stock split in June 2026 and exchanged $142.2 million in Senior Secured Notes due 2026 for new notes due 2029.

Curaleaf Holdings, Inc. announced its voluntary transition to comply with U.S. domestic issuer registration and ongoing reporting requirements, effective August 5, 2026, moving away from foreign private issuer status. As part of this change, the company filed its annual report on Form 10-K for the year ended December 31, 2025, and a quarterly report on Form 10-Q for the three months ended March 31, 2026. Curaleaf also concurrently filed its Form 10-Q for the quarter ended June 30, 2026.

Curaleaf Holdings reported strong second-quarter 2026 financial results, with net revenue increasing 10% year-over-year to $340 million and net income reaching $12 million. The company saw significant growth in both its domestic and international segments, alongside a robust gross profit margin of 50%. Operational highlights include expanding its retail footprint, launching a new premium brand, and completing the buyout of its German subsidiary, Four20 Pharma.

Curaleaf Holdings, Inc. filed updated corporate governance documents, including its Articles of Incorporation effective June 23, 2026, and a revised Insider Trading Policy, Version 5.0, effective July 2025. The filing also included a Notice of Articles issued June 30, 2026, detailing the company's registered office, records office, current directors, and authorized share structure. Additionally, an older coattail agreement from October 2018 was included as an exhibit.

Curaleaf Holdings, Inc. announced the opening of its newest Florida dispensary in Edgewater on July 17, 2026. This expansion increases the company's Florida retail footprint to 74 locations and its total nationwide store count to 166. Chairman and CEO Boris Jordan emphasized the company's focus on serving Florida's growing medical cannabis community, noting that the market serves approximately 4% of the state's population. A grand opening celebration is planned for July 24-25.

Curaleaf Holdings, Inc. announced that the Spanish Agency of Medicines and Medical Devices (AEMPS) has approved the registration of two standardized cannabis preparations. This makes Curaleaf the first company to register under Spain's new regulatory framework, Royal Decree 903/2025, which establishes a national pathway for patient access to standardized cannabis preparations. The registrations enable the supply of these preparations to hospital pharmacies for use in magistral formulas, reinforcing Curaleaf's leadership in the European cannabis market.

Curaleaf Holdings, Inc. announced that its Subordinate Voting Shares have resumed trading under the OTC symbol CURLF, effective July 6, 2026. This marks the conclusion of a temporary 20-trading-day transition period during which shares traded under CURLD, following a 1-for-3 reverse stock split on June 5, 2026. The company stated that no shareholder action is required, and shares continue to trade on the Toronto Stock Exchange under CURA.

Curaleaf Holdings, Inc. announced it will report its financial and operational results for the second quarter ended June 30, 2026, after market close on August 5, 2026. Following the release, the company will host a conference call and audio webcast at 5:00 p.m. ET to discuss the results and provide operational highlights. Details for accessing the live call, webcast, and a replay are provided.

Curaleaf Holdings, Inc. announced the results of its 2026 annual general and special meeting of shareholders. Key approvals include the plan of arrangement to continue the Company out of British Columbia to Delaware, and an amendment to the articles to remove the automatic conversion feature of Multiple Voting Shares. Shareholders also approved an Option Exchange Program for up to 10,070,478 stock options and elected all seven director nominees.